AARDVARK THERAPEUTICS, INC. (AARD) Operating cash flow 2024–2025
AARDVARK THERAPEUTICS, INC. (AARD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.2MFY2025 · since FY2024: -$18.1M → -$54.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.2M | -199.5% |
| FY2024 | -$18.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AARD financial trends
AARD RevenueAARD Net incomeAARD Net marginAARD Gross profitAARD Gross marginAARD Operating incomeAARD Operating marginAARD Free cash flowAARD Capital expendituresAARD Return on equityAARD Stock buybacksAARD Dividends paidAARD Total assetsAARD Total liabilitiesAARD Shareholders’ equityAARD overview →